US
Will the govt risk letting pharma companies go rogue?
Pakistan’s continuing failure to embrace generic drugs is a significant part of the problem
Drug Pricing Policy 2018 grants medicine companies right to increase prices annually by up to 10 %
Amends Drug Pricing Policy 2018 to allow 7% hike in prices of lifesavings drugs; 10% in other drugs
The next hearing of the case will be conducted after 10 days
Clinical trials will be conducted under DRAP supervision soon after approval of vaccines
DRAP issues guidelines for alternative medicines
Says such matters end up in courts for them to decide
Top drug regulator says chloroquine is in trial phase and not being used to treat Covid-19 patients
After health care workers, those working in chemist shops believed to be potential target of the deadly virus